Literature DB >> 26220155

Cytosolic sensing of aberrant DNA: arming STING on the endoplasmic reticulum.

Qiang Wang1, Xing Liu1, Qin Zhou2, Chen Wang1.   

Abstract

INTRODUCTION: Detection of pathogen-derived nucleic acids is a general and effective strategy used by the host to perceive the presence of invading microorganisms and initiate an innate immune response. However, inappropriate detection of aberrant self nucleic acids is implicated in the development of autoimmune diseases. Recently, ER-resident stimulator of interferon genes (STING) has been uncovered as a key component in the innate immune response to cytosolic nucleic acids and a direct sensor for bacterial cyclic dinucleotides. The elucidation of STING-mediated signaling will provide insight into host-microbial interactions and contribute to the development of novel strategies for anti-infection therapies. AREAS COVERED: This review summarizes the cellular and molecular processes of host sensing and responding to microbial or endogenous aberrant DNA species, highlighting the essential function of STING and the corresponding regulatory mechanisms. The authors also attempt to delineate the role for the DNA-sensing signaling during the onset and progression of autoimmune diseases and suggest improvements in the immunogenicity of DNA vaccines. EXPERT OPINION: It is essential to elucidate how the STING-dependent signaling mediates the DNA vaccines action as well as the pathogenesis of autoimmune diseases. The relevant knowledge will greatly benefit the treatment of infectious diseases and identify potential targets for effective drug design.

Entities:  

Keywords:  DNA sensors; DNA vaccines; STING; autoimmune diseases; innate immunity; type I interferon

Mesh:

Substances:

Year:  2015        PMID: 26220155     DOI: 10.1517/14728222.2015.1067303

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  10 in total

1.  High Efficiency CRISPR/Cas9-mediated Gene Editing in Primary Human T-cells Using Mutant Adenoviral E4orf6/E1b55k "Helper" Proteins.

Authors:  Kamila S Gwiazda; Alexandra E Grier; Jaya Sahni; Stephen M Burleigh; Unja Martin; Julia G Yang; Nicholas A Popp; Michelle C Krutein; Iram F Khan; Kyle Jacoby; Michael C Jensen; David J Rawlings; Andrew M Scharenberg
Journal:  Mol Ther       Date:  2016-05-16       Impact factor: 11.454

Review 2.  Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.

Authors:  Kyle M Garland; Taylor L Sheehy; John T Wilson
Journal:  Chem Rev       Date:  2022-02-02       Impact factor: 60.622

3.  SENP7 Potentiates cGAS Activation by Relieving SUMO-Mediated Inhibition of Cytosolic DNA Sensing.

Authors:  Ye Cui; Huansha Yu; Xin Zheng; Rui Peng; Qiang Wang; Yi Zhou; Rui Wang; Jiehua Wang; Bo Qu; Nan Shen; Qiang Guo; Xing Liu; Chen Wang
Journal:  PLoS Pathog       Date:  2017-01-17       Impact factor: 6.823

4.  The catalytic mechanism of cyclic GMP-AMP synthase (cGAS) and implications for innate immunity and inhibition.

Authors:  Justin Hall; Erik C Ralph; Suman Shanker; Hong Wang; Laura J Byrnes; Reto Horst; Jimson Wong; Amy Brault; Darren Dumlao; James F Smith; Leslie A Dakin; Daniel C Schmitt; John Trujillo; Fabien Vincent; Matt Griffor; Ann E Aulabaugh
Journal:  Protein Sci       Date:  2017-10-25       Impact factor: 6.725

5.  The E3 ubiquitin ligase RNF185 facilitates the cGAS-mediated innate immune response.

Authors:  Qiang Wang; Liyuan Huang; Ze Hong; Zhongshi Lv; Zhaomin Mao; Yijun Tang; Xiufang Kong; Senlin Li; Ye Cui; Heng Liu; Lele Zhang; Xiaojie Zhang; Lindi Jiang; Chen Wang; Qin Zhou
Journal:  PLoS Pathog       Date:  2017-03-08       Impact factor: 6.823

6.  Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents.

Authors:  Julie Gaston; Laura Cheradame; Vanessa Yvonnet; Olivier Deas; Marie-France Poupon; Jean-Gabriel Judde; Stefano Cairo; Vincent Goffin
Journal:  Oncotarget       Date:  2016-11-22

7.  Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay.

Authors:  Justin Hall; Amy Brault; Fabien Vincent; Shawn Weng; Hong Wang; Darren Dumlao; Ann Aulabaugh; Dikran Aivazian; Dana Castro; Ming Chen; Jeffrey Culp; Ken Dower; Joseph Gardner; Steven Hawrylik; Douglas Golenbock; David Hepworth; Mark Horn; Lyn Jones; Peter Jones; Eicke Latz; Jing Li; Lih-Ling Lin; Wen Lin; David Lin; Frank Lovering; Nootaree Niljanskul; Ryan Nistler; Betsy Pierce; Olga Plotnikova; Daniel Schmitt; Suman Shanker; James Smith; William Snyder; Timothy Subashi; John Trujillo; Edyta Tyminski; Guoxing Wang; Jimson Wong; Bruce Lefker; Leslie Dakin; Karen Leach
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

8.  Pharmacological Activation of cGAS for Cancer Immunotherapy.

Authors:  Kyle M Garland; Jonah C Rosch; Carcia S Carson; Lihong Wang-Bishop; Ann Hanna; Sema Sevimli; Casey Van Kaer; Justin M Balko; Manuel Ascano; John T Wilson
Journal:  Front Immunol       Date:  2021-11-26       Impact factor: 7.561

Review 9.  Small Molecules Drive Big Improvements in Immuno-Oncology Therapies.

Authors:  Bayard R Huck; Lisa Kötzner; Klaus Urbahns
Journal:  Angew Chem Int Ed Engl       Date:  2018-02-22       Impact factor: 15.336

10.  The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway.

Authors:  Lele Zhang; Ning Wei; Ye Cui; Ze Hong; Xing Liu; Qiang Wang; Senlin Li; Heng Liu; Huansha Yu; Yanni Cai; Quanyi Wang; Juanjuan Zhu; Wei Meng; Zhengjun Chen; Chen Wang
Journal:  PLoS Pathog       Date:  2018-11-02       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.